Exact Sciences Corporation ( EXAS) - Key Metrics
Stock symbol EXAS is outdated, potentially delisted? Maybe it is available on other exchange?
EXAS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $4.63 | -$0.45 | $0.80 | $0.63 |
| 2025Q3 | $4.50 | -$0.10 | $1.16 | $1 |
| 2025Q2 | $4.29 | -$0.01 | $0.47 | $0.25 |
| 2025Q1 | $3.78 | -$0.54 | $0.16 | $0 |
| 2024Q4 | $3.85 | -$4.67 | $0.25 | $0.06 |
EXAS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -56.05 |
| 2025Q3 | ? | -132.11 |
| 2025Q2 | ? | -2117.77 |
| 2025Q1 | ? | -19.98 |
| 2024Q4 | ? | -3.01 |
EXAS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 0.63% | ? |
| 2025Q3 | 1.84% | ? |
| 2025Q2 | 0.46% | ? |
| 2025Q1 | 0.00% | ? |
| 2024Q4 | 0.10% | ? |
EXAS
Price: $104.91
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.09 USD
P/E Ratio: -94.95
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 953316
Ebitda: -23.0 millionMarket Capitalization: 19.8 billion